Editorial, Opinion Piece Discuss Possible Obama Policy Change To Allow Funding For Embryonic Stem Cell Research
Main Category: Stem Cell ResearchAlso Included In: Women's Health / Gynecology
Article Date: 26 Nov 2008 - 9:00 PDT
The Tennessean on Monday published an editorial and an opinion piece examining issues related to embryonic stem cell research.
~ Tennessean: If President-elect Barack Obama issues an executive order to overturn the Bush administration's ban on federal funding for embryonic stem cell research, the way in which he addresses the issue "could be an early sign as to his effectiveness as president," according to the editorial. The editorial says, "The new president would be wise first to thoroughly explain his reasoning for the decision but also do so in ways that persuade, not just inform." The editorial continues that Obama "should also highlight the views of prominent Republicans" who support the research, including former first lady Nancy Reagan and former Sen. Bill Frist (Tenn.). According to the editorial, "Polls have shown that a majority of Americans believe the government should ease current restrictions on the research. The more the new president can illuminate a consensus on the issue the better his efforts will be." It adds, "If Obama wants to make stem cell research a priority, he should make his decision look as inclusive as possible," concluding, "A contentious start on a controversial issue would not be a good way to begin a presidency" (Tennessean, 11/24).
~ Joy Riley, Tennessean: In the opinion piece, Riley -- executive director of the Tennessee Center for Bioethics and Culture -- discusses her opposition to embryonic stem cell research and cites the United Kingdom's regulations on the research as why Obama should not reverse the U.S. funding ban. Citing the "trajectory" of British laws that have gradually lessened restrictions regarding cloning and the use of embryos, Riley writes, "Disrespect for life shown at one point becomes disrespect at every point. We emulate Britain's changes at our peril." She continues, "In using the vulnerable to save those of us not confined to Petri dishes, we are sacrificing more than microscopic cell clumps" (Riley, Tennessean, 11/24).
Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women's Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women's Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company.
© 2008 The Advisory Board Company. All rights reserved.
Visit our stem cell research section for the latest news on this subject.
MLA
12 Feb. 2012. <http://www.medicalnewstoday.com/releases/130853.php>
APA
http://www.medicalnewstoday.com/releases/130853.php.
Please note: If no author information is provided, the source is cited instead.
|
Rate this article: (Hover over the stars then click to rate) |
Patient / Public: |
or |
Health Professional: |
Visitor Opinions In Chronological Order (1)
ESCR Unnecessary!
posted by JohnN on 27 Nov 2008 at 8:32 amPresident-elect Obama is threatening to expand federal funding of embryonic stem cell research but this is a bad policy.
Scientifically, new ESCR funding is looking backward, because the ability to reprogram skin cells to become pluripotent cells (iPS), announced in November 2007, has convinced leaders in stem cell research, such as James Thomson who discovered human embryonic stem cells in 1998, to pursue research using only iPS. It is more efficient to use the readily available patient specific iPS (diseased, as well as non-diseased) which doesn't require risk to women's bodies for ova.
Pluripotent iPS can now be generated without cancer causing viruses opening the door to their use in therapies..
Financially and practically, funding new embryonic stem cell research (ESCR) is foolhardy because, despite billions of dollars spent worldwide, ESCR in ten years has not even provided a proof of concept that it can be used in human therapies, let alone clinical trial or treatment for any disease and it will not for the foreseeable future since ESCs generate tumors and are rejected by the recipient. Such funding would also delay the widespread delivery of 73 treatments already available using stem cells found throughout the body and in the umbilical cord-blood. And now we see stem cells being used to grow a section of windpipe.
It is a bad policy morally because embryonic stem cell research using embryos kills an innocent, defenseless human being; ethically, because the embryo cannot give consent for his/her demise.
President-elect Barack Obama campaigned on change. Those who voted for him expected he would make changes for the better, but funding additional ESCR would be a very bad policy - morally, ethically, financially, practically, and scientifically - and would delay lifesaving treatments from other stem cell sources.
Add Your Opinion
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
All opinions are moderated before being included (to stop spam)
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
![]()
Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.




